Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Xenon Pharmaceuticals Inc.”

102 pharma patents match "Xenon Pharmaceuticals Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 102
Index total 30,257
Page 3 / 5

Quick answer

This filtered view shows 102 pharmaceutical patents matching "Xenon Pharmaceuticals Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

102 results for “Xenon Pharmaceuticals Inc.” · 30,257 patents in full index Clear search

  1. US 8742109

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted Jun 3, 2014 · Expires May 29, 2034

    granted
  2. US 8715968

    Methods and reagents for modulating cholesterol levels

    Xenon Pharmaceuticals Inc. · Granted May 6, 2014 · Expires May 1, 2034

    granted
  3. US 8541457

    Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Sep 24, 2013 · Expires Sep 19, 2033

    granted
  4. US 8507435

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Aug 13, 2013 · Expires Aug 8, 2033

    granted
  5. US 8501746

    Organic compounds

    Xenon Pharmaceuticals Inc. · Granted Aug 6, 2013 · Expires Aug 1, 2033

    granted
  6. US 8466188

    Use of spiro-oxindole compounds as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jun 18, 2013 · Expires Jun 13, 2033

    granted
  7. US 8450358

    Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted May 28, 2013 · Expires May 23, 2033

    granted
  8. US 8445696

    Synthetic methods for spiro-oxindole compounds

    Xenon Pharmaceuticals Inc. · Granted May 21, 2013 · Expires May 16, 2033

    granted
  9. US 8415370

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 9, 2013 · Expires Apr 4, 2033

    granted
  10. US 8410054

    Methods for treating pain by inhibition of the SCN9A channel

    Xenon Pharmaceuticals Inc. · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  11. US 8383628

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  12. US 8263606

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  13. US 8252578

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted
  14. US 8236835

    Heterocyclic inhibitors of stearoyl-CoA desaturase

    Xenon Pharmaceuticals Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  15. US 8153636

    Pyridyl derivatives and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Apr 10, 2012 · Expires Apr 5, 2032

    granted
  16. US 8148378

    Pyridazine derivatives and their use as inhibitors of stearoyl-CoA desaturase-1 activity in a mammal

    Xenon Pharmaceuticals Inc. · Granted Apr 3, 2012 · Expires Mar 29, 2032

    granted
  17. US 8106087

    Spiro-oxindole compounds and their uses as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jan 31, 2012 · Expires Jan 26, 2032

    granted
  18. US 8101647

    Spiro-oxindole compounds and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  19. US 8080651

    Juvenile hemochromatosis gene (HFE2A), expression products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  20. US 8071603

    Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors

    Xenon Pharmaceuticals Inc. · Granted Dec 6, 2011 · Expires Dec 1, 2031

    granted
  21. US 8067219

    Polynucleotide encoding an ATP binding cassette transporter 1 (ABC1) polypeptide

    Xenon Pharmaceuticals Inc. · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted
  22. US 8063084

    Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels

    Xenon Pharmaceuticals Inc. · Granted Nov 22, 2011 · Expires Nov 17, 2031

    granted
  23. US 8049016

    Thiazole derivatives which inhibit stearoyl-CoA desaturase enzymes

    Xenon Pharmaceuticals Inc. · Granted Nov 1, 2011 · Expires Oct 27, 2031

    granted
  24. US 8030488

    Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents

    Xenon Pharmaceuticals Inc. · Granted Oct 4, 2011 · Expires Sep 29, 2031

    granted